Form 4: SEALSQ Corp Insider Trades Ordinary Shares
Statement of Changes in Beneficial Ownership
Andreas Feuardent Moreira, Chief Innovation Officer at SEALSQ Corp, reported transactions involving ordinary shares, including the acquisition of 10,000 shares at $0.01 and the sale of 10,000 shares at $2.31, executed under a Rule 10b5-1 trading plan.
Summary
- Andreas Feuardent Moreira, Chief Innovation Officer at SEALSQ Corp, engaged in transactions involving the company's ordinary shares.
- On April 7, 2026, 10,000 ordinary shares were acquired at a price of $0.01 per share.
- On the same date, 10,000 ordinary shares were disposed of at a price of $2.31 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted by the reporting person's wife on December 8, 2025.
- The reporting person's beneficial ownership of 10,000 ordinary shares is held indirectly through his wife.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While it details insider transactions, the use of a Rule 10b5-1 plan indicates these actions were pre-planned and not necessarily a reaction to new, material information.
Positives
- The acquisition of 10,000 shares at a nominal price of $0.01 suggests a potential benefit or option exercise related to employee compensation or a pre-arranged plan.
- The sale of shares at $2.31 indicates a realization of value, potentially at a profit compared to the acquisition cost or previous market prices.
Negatives
- The sale of 10,000 shares at a significantly higher price than the acquisition price could be interpreted as an insider cashing out, though it was executed under a pre-planned trading strategy.
- The reporting person's beneficial ownership is indirect, held through his wife, which may add a layer of complexity to direct control or decision-making.
Risks
- The Rule 10b5-1 trading plan, while providing an affirmative defense against insider trading allegations, is subject to specific requirements and potential scrutiny if not properly implemented or if market conditions change drastically around the trade dates.
- The significant difference between the acquisition price ($0.01) and the sale price ($2.31) could raise questions about the timing and motivation behind the trades, even within the plan.
Future Outlook
The filing does not contain forward-looking statements or guidance. It reports on past transactions.
Management Comments
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's wife on December 8, 2025.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to diversify holdings or manage personal finances while adhering to insider trading regulations. The specific details of the plan and the price differential are key to understanding the insider's perspective on the stock's valuation.
Related Party Transactions
- The transactions were executed under a Rule 10b5-1 trading plan adopted by the reporting person's wife, indicating a transaction involving a related party (wife).
Stakeholder Impact
- Shareholders: The sale by an insider might be perceived negatively, but the pre-planned nature of the trade under a 10b5-1 plan mitigates concerns about opportunistic selling.
- Employees: The transaction may not have a direct impact, but it reflects the financial activities of a key executive.
- Management: The transaction highlights the use of established compliance mechanisms for personal financial management.
Next Steps
- Continued monitoring of SEALSQ Corp's stock performance and any subsequent insider transactions.
Key Dates
| Date | Description |
|---|---|
| 12/08/2025 | Date Rule 10b5-1 trading plan was adopted by the reporting person's wife. |
| 04/07/2026 | Transaction date for the acquisition and disposition of ordinary shares. |
| 04/08/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
SEALSQ Corp, LAES, Form 4, Insider Trading, Beneficial Ownership, Ordinary Shares, Rule 10b5-1, Stock Transaction, Chief Innovation Officer, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.